A cancer peptide prodrug activated by an oncolytic virus     (128980)
    
  
  
                                                                              
  Polly Chuanrong Sun
      1
  
, 
  Laura Burga
      2
  
, 
  Iman Kavianinia
      1
  
, 
  Margaret Brimble
      1
  
, 
  Mihnea Bostina
      2
  
, 
  Alan Cameron
      1
  
    
              - School of Chemical Sciences, University of Auckland, Auckland, New Zealand
 
              - Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
 
          
   
 
  
     
      Publish consent withheld      
  
          - 1. McCarthy, C.; Jayawardena, N.; Burga, L. N.; Bostina, M. Developing picornaviruses for cancer therapy. Cancers 2019, 11 (5), 685.
 
          - 2. Jayawardena, N.; Burga, L. N.; Easingwood, R. A.; Takizawa, Y.; Wolf, M.; Bostina, M. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus. Proceedings of the National Academy of Sciences 2018, 115 (46), E10934-E10940.